Eli Lilly and Co (NYSE:LLY)
| 204.71 Delayed Data As of Feb 26 |  +0.89 / +0.44%Today’s Change | 117.06 Today|||52-Week Range 218.00 | +21.24% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 203.82 |
| Today’s open | 201.78 |
| Day’s range | 202.09 - 206.99 |
| Volume | 3,887,878 |
| Average volume (3 months) | 4,325,041 |
| Market cap | $192.6B |
Data as of 4:50pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | +4.03% |
| Earnings growth (next 5 years) | +13.20% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 30.2 |
| Price/Sales | 6.28 |
| Price/Book | 34.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.80 | -0.92% |
| ABBVAbbVie | +0.40 | +0.37% |
| MRKMerck | -1.97 | -2.64% |
| PFEPfizer | -0.34 | -1.01% |
Data as of 6:08pm ET, 02/26/2021
Financials
| Next reporting date | April 27, 2021 |
| EPS forecast (this quarter) | $2.19 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
